Comparison of Efficacy of Duloxetine Versus Amitriptyline in Fibromyalgia Patients: Duloxetine vs Amitriptyline in Fibromyalgia Patients

Saira Tahir; Obaid ur  Rehman; Aliena Badshah; Durkho Atif; Muhammad Muddasser Khan Panezai; Alam Zeb

doi:10.55279/jafmdc.v6i2.280

Comparison of Efficacy of Duloxetine Versus Amitriptyline in Fibromyalgia Patients

Duloxetine vs Amitriptyline in Fibromyalgia Patients

Authors

Saira Tahir
Obaid ur Rehman
Aliena Badshah
Durkho Atif
Muhammad Muddasser Khan Panezai
Alam Zeb

DOI:

https://doi.org/10.55279/jafmdc.v6i2.280

Keywords:

Amitriptyline, Duloxetine, Fibromyalgia, Symptom Severity Scale, Widespread Pain Index

Abstract

ABSTRACT
Objective: To compare the outcomes of Duloxetine and Amitriptyline therapy in fibromyalgia patients regarding change in Symptom Severity Scale (SSS) score and Widespread Pain Index (WPI) from baseline after three months of treatment.
Methodology: This quasi-experimental study was done in the Department of Rheumatology, Pakistan Institute of Medical Sciences, Islamabad, from November 2022 to April 2023. One hundred fifty-six fibromyalgia patients of either gender between the ages of 25-70 years were included in the study. They were erratically assigned into two groups. Group A patients were given Duloxetine, while group B patients were given Amitriptyline for 12 weeks with main outcome of change in WPI and SSS scores three months after the therapy.
Results: There were 2.6% (n=2/78) males and 97.4% (n=76/78) females in group A and 1.3% (n=1/78) males and 98.7% (n=77/78) females in group B (P=0.560). At baseline, the mean WPI score in group A was 15.8 ± 1.3 SD, and it was 16.1 ± 1.4 SD in group B (P=0.286), and the mean SSS score was 6.6 ± 1.6 SD in group A, and it was 6.8 ± 1.5 SD in group B (P=0.467). At 12 weeks, the mean WPI score in group A was 11.2 ± 2.2 SD, and it was 8.9 ± 3.1 SD in group B (P=0.001), and the mean SSS score was 4.5 ± 1.7 SD in group A, and it was 3.6 ± 1.3 SD in group B (P=0.001).
Conclusions: Outcomes were better with Amitriptyline compared to those patients taking Duloxetine in diagnosed cases of fibromyalgia.

Downloads

Published

2024-12-21

How to Cite

Tahir, S., Rehman, O. ur ., Badshah, . A., Atif, D., Khan Panezai, M. M., & Zeb, A. (2024). Comparison of Efficacy of Duloxetine Versus Amitriptyline in Fibromyalgia Patients: Duloxetine vs Amitriptyline in Fibromyalgia Patients. Journal of Aziz Fatimah Medical & Dental College, 6(2), 89–95. https://doi.org/10.55279/jafmdc.v6i2.280

Download Citation

Issue

Vol. 6 No. 2 (2024): Journal of Aziz Fatimah Medical and Dental College

Section

Original Articles

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons Attribution-NonCommercial 4.0.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Non Commercial — You may not use the material for commercial purposes.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.